Evidence map›Paper›PMID 40229558›Full record

ArticleMolecular systems biology2025

Spatial proteomics in translational and clinical research.

Peter Horvath, Fabian Coscia

Abstract read
In one paragraph

Article in Molecular systems biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. MR-SPJournal of proteome research · 2026
    Article
  9. Review
  10. Review
  11. Post-Translational Regulation of CD8Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  12. Review
  13. Review
  14. Review
  15. Future Research Directions on Mycobacterium tuberculosis Proteins.Advances in experimental medicine and biology · 2026
    Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Peter HorvathSynthetic and Systems Biology Unit, Biological Research Centre, HUN-REN, Szeged, Hungary. horvath.peter@brc.hu.ORCID http://orcid.org/0000-0002-4492-1798
Fabian CosciaMax-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Spatial Proteomics Group, Berlin, Germany. fabian.coscia@mdc-berlin.de.ORCID http://orcid.org/0000-0002-2244-5081

Funding

Bundesministerium für Bildung und Forschung (BMBF) 161L0222EC | ERC | HORIZON EUROPE European Research Council (ERC) 101115681European Commission (EC) H2020-Fair-CHARM, 101016457European Commission (EC) Horizon-SWEEPICS, 101135053HAS HAS-NAP3, NAP2022-I-6/2022National Research, Development and Innovation Office Horizon-BIALYMPHNational Research, Development and Innovation Office Horizon-SYMMETRYNational Research, Development and Innovation Office NKKP- ADVANCED 24 - 151202National Research, Development and Innovation Office TKP2021-EGA09, TKP-31-8/PALY-2021
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40229558
PMCPMC12130312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.